ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years
Liang Han
Matched on OpenAlex author ID A5159750387. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- Patient survival outcomes in brain metastases of pancreatic ductal adenocarcinoma: A comprehensive analysis. Co-author DOI 10.1016/j.ctarc.2026.101266↗
- A qualitative study on the disease coping experiences of pancreatic cancer patients and their spouses. Last author DOI 10.1038/s41598-024-69599-7↗
- Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway. Co-author DOI 10.2174/09298673113209990251↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuanchi Ma · 1 shared paper, 2026 · strength 0.33
- Kongyuan Wei · 1 shared paper, 2026 · strength 0.33
- Hairong He · 1 shared paper, 2026 · strength 0.33
- Qingyong Ma · 2 shared papers, 2013–2024 · strength 0.31
- Paper A qualitative study on the disease coping experiences of pancreatic cancer patients and their spouses. DOI 10.1038/s41598-024-69599-7↗
- Paper Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/… DOI 10.2174/09298673113209990251↗
- Bo Zhang · 1 shared paper, 2024 · strength 0.28
- Jingtao Gu · 1 shared paper, 2024 · strength 0.28
- Wei Li · 1 shared paper, 2013 · strength 0.03
- Jiangbo Liu · 1 shared paper, 2013 · strength 0.03
- Erxi Wu · 1 shared paper, 2013 · strength 0.03
- Jiguang Ma · 1 shared paper, 2013 · strength 0.03
- Wanxing Duan · 1 shared paper, 2013 · strength 0.03
- Qinhong Xu · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.